Bringing lyophilized drug delivery into patients’ hands

In the latest issue of Pharmaceutical Manufacturing and Packing Sourcer (PMPS), SHL Medical expands the discussion on the challenges posed by liquid-unstable drugs and examines how lyophilization – combined with advanced dual-chamber delivery systems – is reshaping modern drug formulation and administration. 

The article features Reunite™, SHL Medical’s newest addition to its product portfolio, highlighting how its dual-chamber, automated reconstitution mechanism simplifies the preparation of lyophilized (freeze-dried) formulations by streamlining a complex multistep process into a user-friendly three-step experience. Powered by SHL Medical’s proprietary Needle Isolation Technology (NIT®), Reunite enhances dose accuracy, usability, and patient safety while supporting the broader use of complex biologic formulations. 

Read the full article to learn how SHL Medical is advancing next-generation drug delivery solutions that promote self-administration and expand access to innovative therapies.